SCHEMBL24639012

SCHEMBL24639012

c1ccc(-c2ccc3c(c2)c2cc(-c4ccccc4)ccc2n3-c2cccc(-c3ccc(-c4cccc5c4c4c6ccccc6oc4n5-c4ccccc4)cc3)c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PLA2G2A P14555 3/20 0.34
PLA2G4A P47712 3/20 0.34
PLA2G10 O15496 1/20 0.33
PDE10A Q9Y233 1/20 0.31
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
POLB P06746 1/20 0.31
TSHR P16473 1/20 0.31
BRCA1 P38398 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TSPO P30536 1/20 0.30
IL1R1 P14778 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24639584 0.98 KDM4E (0.35) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL24639011 0.97 KDM4E (0.35) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL24638942 0.97 KDM4E (0.36) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL24639008 0.97 KDM4E (0.36) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL24638945 0.96 KDM4E (0.37) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL24639007 0.96 KDM4E (0.37) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL24638941 0.96 KDM4E (0.38) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL24639577 0.96 KDM4E (0.38) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL24639005 0.96 L3MBTL1 (0.40) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL24638943 0.94 KDM4E (0.40) KDM4EATML3MBTL1PLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220310934-A1 COMPOUND INCLUDING NITROGEN EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220310934-A1 COMPOUND INCLUDING NITROGEN EMITTING DEVICE INCLUDING THE SAME NOS1, NOX1, NPM1 KDM4E 1775/4885ATM 3242/4885L3MBTL1 1046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.